Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer

Conclusions
Patients with IBD with a history of cancer are at increased risk of developing any (new or recurrent) cancer, with a predominant incidence of new cancers. Treatment with immunosuppressants has no overall major impact per se on this risk.

Source: Gut - August 3, 2014 Category: Gastroenterology Authors: Beaugerie, L., Carrat, F., Colombel, J.-F., Bouvier, A.-M., Sokol, H., Babouri, A., Carbonnel, F., Laharie, D., Faucheron, J.-L., Simon, T., de Gramont, A., Peyrin-Biroulet, L., for the CESAME Study Group Tags: Inflammatory bowel disease Source Type: research